(2,5-Dichlorophenyl)methanesulfonyl chloride, 95%, 1g

3-Chloro-4-(3-pyridin-2-yl-ureido)benzenesulfonylchloride hydrogen sulfate, 250mg

2-Phenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazole, 97%, 500mg

Ser-Ala-OH, 98.0%, 100mg

2,4,6-Trichlorophenoxyacetic Acid>98.0%(GC)(T)25g

1-Propanol, min 99,5 %, pour la synthèse, 2,5 l, emballage en verre

1-Pyrrolidinecarboxylic acid, 3-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-, phenylmethyl ester, (3R)-, 95%, 1g

5-FLUORO-2,3-DIHYDROBENZOFURAN-7-AMINE, 95%, 100mg

Colonne capillaire GC ROTI®Cap-1, 30 m, 0,25 mm, 1,00 µm, 1 pièce(s)

2-(tetrahydro-2H-pyran-3-yl)ethanamine, 95.0%, 1g

2-(DIMETHOXYMETHYL)-2-METHYL-6-NITRO-2H-CHROMENE, 90.0%, 100mg

N-(tert-butoxycarbonyl)-N-isopropylphenylalanine, 98%, 250mg

(S)-2-(6-HYDROXY-2,3-DIHYDROBENZOFURAN-3-YL)ACETIC ACID, 95.0%, 1g